Grey Wolf Health Corp.
WOLF.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.19% | 14.04% | 34.88% | 34.02% | 30.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.19% | 14.04% | 34.88% | 34.02% | 30.87% |
| Cost of Revenue | 8.90% | 10.56% | 30.36% | 29.08% | 21.82% |
| Gross Profit | 7.62% | 17.16% | 39.35% | 38.79% | 39.06% |
| SG&A Expenses | 20.82% | 19.48% | 5.53% | 29.86% | 32.29% |
| Depreciation & Amortization | -2.31% | -10.81% | 35.05% | 81.97% | 74.27% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.24% | 12.78% | 19.09% | 31.65% | 28.25% |
| Operating Income | -18.48% | 30.42% | 685.70% | 51.12% | 46.71% |
| Income Before Tax | -25.81% | 245.36% | 198.10% | 12.86% | 15.86% |
| Income Tax Expenses | -3.83% | 140.27% | -2.21% | 23.11% | -6.76% |
| Earnings from Continuing Operations | -34.81% | 450.00% | 165.98% | 8.26% | 28.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.81% | 450.00% | 165.98% | 8.26% | 28.64% |
| EBIT | -18.48% | 30.42% | 685.70% | 51.12% | 46.71% |
| EBITDA | -16.15% | 11.46% | 369.29% | 62.03% | 58.60% |
| EPS Basic | -35.22% | 400.00% | 150.35% | -1.68% | 16.91% |
| Normalized Basic EPS | -26.43% | 250.00% | 174.67% | 2.80% | 5.26% |
| EPS Diluted | -35.22% | 383.33% | 135.43% | -1.68% | 16.91% |
| Normalized Diluted EPS | -26.43% | 240.00% | 174.67% | -0.93% | 5.26% |
| Average Basic Shares Outstanding | 0.95% | 0.58% | 31.42% | 10.18% | 10.18% |
| Average Diluted Shares Outstanding | 0.95% | 1.20% | 31.42% | 14.71% | 10.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |